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Abstract In this study, free cholesterol (FC) efflux medi­
ated by human HDL was investigated using fluorescence 
methodologies. The accessibility of FC to HDL may de­
pend on whether it is located in regions rich in unsaturated 
phospholipids or in domains containing high levels of FC 
and sphingomyelin, known as “lipid rafts.” Laurdan gener­
alized polarization and two-photon microscopy were used to 
quantify FC removal from different pools in the bilayer of 
giant unilamellar vesicles (GUVs). GUVs made of POPC 
and FC were observed after incubation with reconstituted 
particles containing apolipoprotein A-I and POPC [78A 
diameter reconstituted high density lipoprotein (rHDL)]. 
Fluorescence correlation spectroscopy data show an in­
crease in rHDL size during the incubation period. GUVs 
made of two “raft-like” mixtures [DOPC/DPPC/FC (1:1:1) 
and POPC/SPM/FC (6:1:1)] were used to model liquid- 
ordered/liquid-disordered phase coexistence. Through 
these experiments, we conclude that rHDL preferentially 
removes cholesterol from the more fluid phases.QQ These 
data, and their extrapolation to in vivo systems, show the 
significant role that phase separation plays in the regulation 
of cholesterol homeostasis.—Sanchez, S. A., M. A. Tricerri, 
and E. Gratton. Interaction of high density lipoprotein par­
ticles with membranes containing cholesterol. J. Lipid Res. 
2007. 48: 1689-1700.
Supplementary key words raft mixtures • giant unilamellar vesicles • 
two-photon microscopy • 6-lauroyl-2-(dimethylamino) naphthalene
It is generally accepted that the chronic, progressive 
pathologies atherosclerosis and coronary heart disease are 
characterized by two processes: recruitment of inflamma­
tory cells from the circulation, and accumulation of lipids 
in the artery wall. An excess of unesterified free cholesterol 
(FC) is toxic to cells; therefore, several mechanisms trig­
gering its clearance have been identified. Extensive epide­
miological research supports a key role of HDLs and their 
major apolipoprotein A-I (apoA-I) in the prevention of 
coronary heart disease. Different protective capabilities
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have been attributed to HDL (1-3) , including their critical 
participation in cholesterol catabolism.
Human plasma HDLs, a population of particles highly 
heterogeneous in lipid and apolipoprotein composition 
as well as size and shape, are the main cholesterol ac­
ceptors in vivo. In particular, recent research has shown 
that a nascent subspecies of HDL, preP-HDL, containing 
apoA-I as its sole protein moiety, removes lipids very ef­
ficiently from cells (4), interacts with LCAT (5) , and un­
dergoes further metabolism to yield mature circulating 
spherical lipoproteins.
Two major mechanisms have been proposed to explain 
the efficiency of HDL in promoting cholesterol efflux. The 
first pathway involves the interaction of lipid-free or lipid- 
poor apolipoproteins with ABCA1 (6) and the formation 
of new particles by cellular lipid and extracellular apo­
lipoproteins. This process is unidirectional and requires 
ATP as an energy source, mediating not only the removal 
of FC from the plasma membrane but the mobilization of 
internal pools as well. In addition to the ABCA1 trans­
porter, which is highly expressed in liver and macro­
phages, ABCG1 and ABCG4 mediate cholesterol transport 
in tissue macrophages and brain cells, respectively (6).
A second mechanism for FC removal is a nonspecific 
efflux from the plasma membrane by physicochemical, 
passive exchange between the cell membrane and extra­
cellular acceptors. This process is favored by extracellular 
cholesterol esterification by LCAT, which, when activated 
by apoA-I, drives the mass action kinetics of the aqueous 
diffusion mechanism.
The importance of passive lipid removal maintaining 
lipid homeostasis has been addressed (7). Both diffusion-
Downloaded from www
 jlr.org by guest, on August 23, 2019
Abbreviations: apoA-I, apolipoprotein A-I; DOPC, 1,2-dioleoyl- 
sm-glycero-3-phosphocholine; DPPC, l,2-dipalmitoyl-sn-glycero-3- 
phosphocholine; FC, free cholesterol; FCS, fluorescence correlation 
spectroscopy; GP, generalized polarization; GUV, giant unilamellar 
vesicle; LAURDAN, 6-lauroyl-2-(dimethylamino) naphthalene; lo ld, 
liquid-ordered and liquid-disordered phases, respectively; MpCD, 
methyl-p-cyclodextrin; rHDL, reconstituted high density lipoprotein; 
SPM, porcine brain sphingomyelin.
1 To whom correspondence should be addressed.
e-mail: susanas@uci.edu
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology, Inc.
This article is available online at http://www.jlr.org Journal of Lipid Research Volume 48, 2007 1689
JO
UR
NA
L 
O
F L
IP
ID
 R
ES
EA
RC
H 
jg
AS
BM
B
mediated and scavenger receptor class B type I efflux 
occur to phospholipid-containing acceptors, and in con­
trast to the ABCA1 pathway, FC transfer is bidirectional 
(8). The extent and direction of the net movement depend 
on the ratio of efflux to influx and are determined by the 
properties of the acceptor and donor (9). It has been pro­
posed that factors reducing the packing density of lipid mol­
ecules would enhance the rate of cholesterol transfer (10).
The distribution of lipids at the plasma membrane is not 
homogenous. It is known that cholesterol together with 
saturated lipids, sphingomyelin, and proteins form dis­
crete structures called lipid rafts (11, 12) , which have been 
associated with important biological processes such as en- 
docytosis, adhesion, signaling, protein transport, apopto­
sis, and cytoskeleton organization (13). Both raft domains 
and the surrounding lipid matrix are liquid phases, but 
lipid rafts are a more organized phase (liquid-ordered) (14).
Here, we report the effect of cholesterol distribution 
and the lipid packing of the bilayer on the removal of the 
sterol by HDL particles. To facilitate the interpretation of 
the results, we selected well-defined model systems: recon­
stituted high density lipoprotein (rHDL) particles and giant 
unilamellar vesicles (GUVs). rHDLs, having two apoA-I 
molecules per particle and variable phospholipid content, 
are particularly useful models and are well characterized. 
The specie selected for this study have well-defined diame­
ter (78 A) , a known apoA-I conformation (15) , the capac­
ity to activate LCAT (5) , and binding affinity for scavenger 
receptor class B type I receptor (16) and POPC bilayers 
(17). GUVs constitute an ideal model for microscopic 
studies because of their size (20-50 |xm) ; this fact permits 
the direct observation of micrometer-scale domains that 
can be observed directly by fluorescence microscopy and 
the study of liquid phases from a more controlled physical 
perspective than is possible in cells. The GUVs have been 
used extensively in different studies (18-23) , and we have 
used them to study the interaction of phospholipase A2 
(24), apoA-I, and rHDL with lipid bilayers (17, 25, 26). We 
used LAURDAN generalized polarization (GP) imaging 
to characterize phase organization in GUVs made of dif­
ferent lipid mixtures containing cholesterol, and we show 
the usefulness of this technique to quantify the kinetics of 
cholesterol removal from different membrane pools.
Our previous observations in lipid-free apoA-I (25) show 
that the interphase in the areas where the liquid-ordered 
and liquid-disordered (lo and ld) phases meet facilitates 
the solubilization of lipids preferentially from the liquid 
phase of the mixture. The experiments presented here 
show that in the case of rHDL, phase separation is not a 
necessary condition for lipid (phospholipid and choles­
terol) solubilization. A more important criterion is the 
accessibility of cholesterol defined by the particular char­
acteristic of the lipids present at the bilayer.
MATERIALS AND METHODS
Human apoA-I was purified from blood plasma purchased 
from the Champaign County Blood Bank, Regional Health Cen­
ter, as described previously (27). Porcine brain sphingomyelin 
(SPM), FC, and phospholipids were obtained from Avanti Polar 
Lipids (Alabaster, AL) and used without further purification. 
The phospholipids used were POPC, l,2-clipalmitoyl-.sn-glycero-3- 
phosphocholine (DPPC), and l,2-clioleoyl-.sn-glycero-3-phospho- 
choline (DOPC). Alexa 488 (Alexa Fluor, 488 carboxylic acid, 
succinimiclyl ester) and LAURDAN were purchased from Molec­
ular Probes (Eugene, OR). Tris (hydroxymethyl) aminomethane 
hydrochloride (Trizma HC1) was obtained from Sigma Biochemi­
cals (St. Louis, MO).
Alexa 488 labeling of apoA-I
Labeling of apoA-I with Alexa 488 was done according to pub­
lished protocols (17). Briefly, apoA-I (2-4 mg) in 0.1 M sodium 
bicarbonate, pH 8.3, was incubated with Alexa 488 (dissolved in 
the same buffer) at a molar ratio 30:1 probe to protein. After 2 h 
of incubation in the dark at room temperature, unreactecl probe 
was separated by elution through a NAP 5 column (Amersham 
Biosciences, Uppsala, Sweden), followed by overnight dialysis 
against 10 mM Tris, 0.15 M NaCl, 1 mM NaN3, and 0.1 mM EDTA, 
pH 8.0 (TBS). The efficiency of labeling of amino groups in 
apoA-I was determined from absorbance measurements on the 
conjugate at 280 nm (^28o = 57,800 M 1 for the probe and 
30,700 M ’ for apoA-I) and at 492 nm 192 = 71,000 M 1 for 
Alexa 488) (28). Under these conditions, approximately one 
molecule of probe was bound per molecule of apoA-I.
Preparation of rHDL
rHDL particles of 78 A diameter were prepared by the so­
dium cholate dialysis method (29), using a starting molar ratio of 
POPC/protein/soclium cholate of 35:1:60. The desired amount 
of POPC in CHC13 was dried under N2, and the lipids were dis­
persed in TBS; sodium cholate was added, and the mixture was 
kept at 37“C until the lipid dispersion cleared. Next, the mixed 
micelles were incubated in the presence of the proteins for 1 h at 
37 “C and dialyzed extensively against TBS at 4“C. The homoge­
neity and hydrodynamic diameter of the rHDLs were estimated 
by native (8-25%) polyacrylamide gradient gel electrophoresis 
on a Pharmacia Phast System. Protein was quantified either by 
absorbance at 280 nm or with the Bio-Raci Protein Assay (Bio- 
Raci, Hercules, CA). When necessary, preparations were passed 
through a Superclex 200 HR 10/30 column (Pharmacia FPLC 
System) equilibrated with the same buffer at a flow rate of 
0.25 ml/min. Fractions that were free of higher molecular weight 
complexes after the first column elution were concentrated ancl 
further purified by a second chromatographic step. For this step, 
the same column was equilibrated with TBS plus 0.1 M guanidine 
hydrochloride, ancl a flow rate of 0.4 ml/min was used. After the 
elution, pure fractions were clialyzecl against TBS.
GUV formation
The protocol to form GUVs is a modified version of the 
method published by Angelova ancl colleagues (18, 19). Briefly, 
stock solutions of phospholipids were prepared in chloroform at 
a concentration of 0.2 mg/ml. Two microliters of the stock was 
aclclecl to each platinum wire of the growing chamber ancl dried 
under N2 for min to remove any traces of the remaining 
solvent. The chamber was sealed with a cover slip ancl thermo- 
stattecl with a water-circulating bath at the growing temperature 
(normally 10“C over the corresponding transition temperature 
of the lipicl). Immediately before connecting the platinum wires 
to the function generator (Hewlett-Packard, Santa Clara, CA), 
1 mM Tris buffer, pH 8.0 (previously warmed up to the growing 
temperature), was aclclecl to the chamber. Temperature was moni­
tored by a digital thermocouple (model 400B; Omega, Stamford,
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CT) in contact with the wires. A low-frequency alternating current 
field (frequency, 10 Hz; amplitude, 2 V) was applied to the plati­
num wires to grow the vesicles by the electroformation method. 
A charge-couplecl device color video camera (CCD-Iris; Sony) 
attached to the microscope allowed visualization of vesicle forma­
tion and selection of the target GUVs.
GP image measurements
LAURDAN GP. LAURDAN is used as a membrane probe be­
cause of its large excitecl-state dipole moment, which results in its 
ability to report the extent of water penetration into the bilayer 
surface as a result of the dipolar relaxation effect (30). Water 
penetration has been correlated with lipid packing and mem­
brane fluidity (31, 32). The emission spectrum of LAURDAN in 
a single phospholipid bilayer is centered at 440 nm when the 
membrane is in the gel phase and at 490 nm when it is in the 
liquid crystalline phase. The GP gives a mathematically conve­
nient and quantitative way to measure the emission shift. The 
function is given by:
GP ~ 1440 ~ 1490 (7)
I44o + I490
where I440 and I490 are the emission intensities at 440 and 
490 nm, respectively. A full discussion of the use and mathemati­
cal significance of GP can be found in the literature (32, 33). If 
LAURDAN is solubilized in a lipiclic structure, such as a lipo­
some, its spectrum will move according to the water content of 
the bilayer. The fluorescence emission of LAURDAN at the liquid- 
ordered bilayer is blue-shiftecl, compared with the emission from 
the liquid-disordered bilayer, allowing identification of the phase 
of the lipid domain directly from the GP image. To calculate the 
GP value in a two-photon microscope, an excitation wavelength of 
780 nm and a two-channel system with the corresponding filters 
on the emission are used (see below for details).
Experimental setup. Images were collected on a scanning two- 
photon fluorescence microscope designed at the Laboratory 
for Fluorescence Dynamics (University of Illinois at Urbana- 
Champaign, Urbana, IL) (34, 35). A LD-Achroplan 20X long- 
working-clistance air objective with a numerical aperture of 0.4 
(Zeiss, Holmclale, NJ) was used. A mode-locked titanium- 
sapphire laser (Mira 900; Coherent, Palo Alto, CA) pumped by 
a frequency-doubled Ncbvanaclate laser (Verdi; Coherent) and 
set to 780 nm was used as the two-photon excitation light source. 
A galvanometer-clriven x-t scanner was positioned in the excita­
tion path (Cambridge Technology, Watertown, MA) to achieve 
beam scanning in both the x and t directions. Samples received 
from 5 to 9 mW of 780 nm excitation light, and a frame rate of 
9frames/s was used to acquire the 256 X 256 pixel images. A quar­
ter wave-plate (CVI Laser Corp., Albuquerque, NM) was aligned 
and placed in the path of the beam before the light entered the 
microscope to minimize the polarization effects of the excita­
tion light. Fluorescence emission was observed through a broad 
band-pass filter from 350 to 600 nm (BG39 filter; Chroma Tech­
nology, Brattleboro, VT). A miniature photomultiplier (R5600-P; 
Hamamatsu, Bridgewater, NJ) was used for light detection in the 
photon-counting mode, and counts were acquired using an ISS 
card (ISS, Inc., Champaign, IL).
A two-channel detection system was attached for GP image col­
lection. The fluorescence was split into red and blue channels 
using a Chroma Technology 470DCXR-BS dichroic beam splitter 
in the emission path. Interference filters (Ealing 490 and Ealing 
440) were placed in the emission paths to further isolate the red 
and blue parts of the emission spectrum. Separate detectors were 
used for each channel to simultaneously collect 490 and 440 nm 
emission. Red and blue images were collected simultaneously 
and then recombined to form the GP image of the sample using 
the SimFCS program (Laboratory for Fluorescence Dynamics). 
Corrections for the wavelength dependence of the emission de­
tection system were accomplished through the comparison of 
the GP value of a known solution (LAURDAN in DMSO) (21, 36) 
taken on an ISS Inc. model PCI steady-state fluorometer and 
then in the microscope.
GP data analysis. Two simultaneous 256 X 256 pixel images are 
obtained from the vesicle (image channel 1 and image chan­
nel 2), which are processed applying the GP formula (equation 1) 
to each pixel of the image using the SimFCS program. The re­
sulting image (GP image) can be represented in a histogram of 
the number of pixels with a given GP. The center of the histo­
gram represents the average GP. GP values can range from —1 to 
+ 1 according to equation 1, and a color scale is used to visualize 
pixels with different GP values.
When the mixture presents areas with different GP values, both 
the histogram and the GP image can be cleconvolutecl into higher 
and lower GP values, and then the average GP will be given by
GPavg = GPixfi + GP2xf2 (2)
where i , and f2 correspond to the fractional contributions of the 
components with higher (GPj) and lower (GP2) GP values.
GP kinetics measurements. GUVs were grown as explained previ­
ously at 60“C in 1 mM Tris, pH 8.0. Temperature was monitored 
continuously using a thermocouple attached to the platinum 
wires. For GP measurements, LAURDAN in DMSO was added to 
the GUVs (in a 1:300 LAURDAN/lipicl molar ratio) and incu­
bated for 15 min. For the kinetics experiments, the temperature 
was decreased to the desired value and the time zero GP image 
was taken. To ensure quick mixing, cholesterol acceptors [apoA- 
I, rHDL, and methyl-p-cycloclextrin (M(3CD)] were previously di­
luted in the growing buffer and then added to the chamber. For 
most of the experiments, the final concentration of apoA-I or 
rHDL in the solution was 0.35 pM pg/ml (expressed as pro­
tein concentration). After addition of the acceptors, GP images 
were taken every 15 min for 2 h. To prevent morphological 
changes in the GUV attributable to osmotic differences, dextrins 
were prepared in 1 mM Tris, pH 8.0, and particles and apoA-I 
were dialyzed overnight against the same buffer.
Fluorescence correlation spectroscopy measurements
Fluorescence correlation spectroscopy. Fluorescence correlation 
spectroscopy (FCS) is widely used and well-described in numer­
ous reports (37-41). Briefly, FCS measures the fluctuations in 
fluorescence produced when the fluorescent molecules move 
through the illuminated volume. The analysis of these types of 
fluctuations can be done with the autocorrelation or with the 
photon-counting histogram method. The autocorrelation function, 
G(t), characterizes the time-dependent decay of the fluorescence 
fluctuations to their equilibrium value. From the autocorrelation 
function, one can recover two parameters: the diffusion coefficient 
and the average number of particles in the observation volume 
(N), which is given by the inverse of G(0). In the photon-counting 
histogram approach, the probability of detecting a given number 
of photons per sampling time is determined. This probability is 
experimentally determined using a histogram of the photons de­
tected per bin time. Two parameters will characterize the photon 
distribution: the number of molecules in the observation volume 
(N) and the molecular brightness ((3), defined as the average num­
ber of photons detected per sampling time per second (42).
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Microscope setup. For FCS measurements, a microscope setup 
similar to that used for the GP measurements was used. The dif­
ferences were as follows: i) the excitation light source for 780 nm 
was a mode-locked titanium-sapphire laser with 80 MHz, 100 fs 
pulse width (Tsunami; Spectra-Physics, Mountain View, CA); H) 
a one-channel setup with a photomultiplier tube (Hamamatsu 
R7400P) was used for light detection in the photon-counting 
mode; and Hi) a BG39 optical filter (Chroma Technology) was 
placed before the photomultiplier for the suppression of infrared 
excitation light. A Zeiss C-Apo 40X (1.2 numerical aperture) 
water-immersion objective lens was used for the measurement.
FCS kinetics measurements. POPC/FC (2:1 molar ratio) GUVs 
were grown at 25°C in 2 ml of 1 mM Tris, pH 8.0. Alexa 488- 
labelecl rHDLs were added to the growing chamber as explained 
above. The system was thermostattecl using a water bath, and the 
temperature was monitored with a thermocouple attached to the 
platinum wires. Every 15 min for 2 h, an image of the GUV was 
taken and the laser was directed to a point just outside the GUV 
to perform the FCS measurement.
FCS data analysis. Experimental autocorrelation functions 
were fit using a Gaussian-Lorentzian intensity profile model, as 
described previously (24, 37), which contains the formulas for 
the point-spread function and the definition of the beam waist 
used. The beam waist of the excitation profile function depends 
on the instrument setup and must be calibrated each time the sys­
tem is aligned; for this purpose, fluorescein was used. In 25 mM 
Tris buffer (pH 8.0) at 25“C, fluorescein has a diffusion coefficient 
of 300 gm2/s (38). The recovered beam waist value of 0.41 pm was 
used to perform the autocorrelation analysis and determine the 
diffusion coefficient of the Alexa 488-labelecl rHDL particles 
during their interaction with the GUVs. Photon-counting analysis 
was also done to determine the molecular brightness and the par­
ticle number of the labeled rHDL particles during the kinetics, 
assuming a Gaussian-Lorentzian intensity profile. Both types of 
analysis were performed using the program SimFCS (Laboratory 
for Fluorescence Dynamics).
RESULTS
Changes in GP are attributable to changes in 
cholesterol content
GUVs made of POPC plus different amounts of choles­
terol were grown in independent chambers, incubated 
with LAURDAN, and the GP images of 10 GUVs were 
taken and averaged. The point-spread function of the two- 
photon excitation defines an illumination volume close 
to a 1 fL with a geometry that gives a distance in Z plane of 
~1-1.5 pm. Therefore, a 1 pm slice taken at the center of 
the spherical liposome will appear as a fluorescent ring 
corresponding to LAURDAN emission within the phos­
pholipid bilayer with a black nonfluorescent central area 
(LAURDAN does not fluoresce in water).
Figure 1A shows the plot of GP as a function of cho­
lesterol content. As cholesterol concentration increases, 
GP increases at 25°C and 37°C in a linear trend until 
45 mol%. To correlate the changes in GP value and the cho­
lesterol content in the bilayer, GUVs containing choles­
terol were incubated with increasing concentrations of a 
well-known cholesterol acceptor, MpCD (23, 43, 44). Fig­
ure IB shows the dependence of the GP on the MpCD 
concentration at 25°C. A linear trend was observed until 
800 pM MpCD. A linear dependence in the same concen­
tration range was also observed at 37°C (data not shown). 
This last concentration was enough to decrease the GP to 
the value measured in GUVs containing only POPC. At 
dextrin concentrations > 800 pM, the GUVs shrank.
Cholesterol removal by rHDL
rHDLs are also known as cholesterol acceptors. Fig­
ure 1C shows that GP in POPC/FC (2:1) GUVs decreases 
in a linear manner when incubated for 2 h with increasing 
concentrations of 78 A rHDL at 25°C. This trend is ob-
Fig. 1. Generalized polarization (GP) changes as a function of cholesterol content. A: Giant unilamellar vesicles (GUVs) made of POPC 
plus different percentages of cholesterol were grown at 25°C (squares) and 37°C (circles). Independent chambers were prepared for 
each cholesterol concenriation. Lines correspond to dre linear fit of the experimental data at 25°C [GP = 0.197 + 0.679 X 10 2 X % free 
cholesterol (FC)] and at 37°C (GP = —0.026 + 0.846 X 10 2 X % FC), and images show an example of a GUV at each cholesterol 
concentration using die same scale and color code. B, C: Different concentrations of mediyl-|3-cyclodextrin (M|3CD) (B) and reconstituted 
particles of 78 A diameter (C) were added to POPC/FC (2:1) GUVs at 25°C and incubated for 2 h. Average GP values of 10 GUVs and SD 
are shown. rHDL, reconstituted high density lipoprotein.
Downloaded from www.jlr.org by guest, on August 23, 2019
1692 Journal of Lipid Research Volume 48, 2007
JO
UR
NA
L 
O
F L
IP
ID
 R
ES
EA
RC
H 
jg
AS
BM
B
served in the range 0-0.56 p,M (calculated as protein con­
centration), a concentration range 1,000 times lower than 
that required for MpCD to achieve the same GP changes.
The time courses of the GP changes when POPC/FC 
GUVs are incubated with 0.35 p,M rHDL at 25°C and 37°C 
are shown in Fig. 2. At 25°C, the GP decreases from 0.39 to 
0.26, and at 37°C, it decreases from 0.25 to 0.12. The data 
from Fig. 1A can be used to calculate the amount of cho­
lesterol removed from the bilayer. After 2 h, similar amounts 
of cholesterol are removed at both temperatures (19.4 ± 
0.5% at 25°C and 14.1 ± 0.3% at 37°C); however, the pro­
cess is faster at 37°C (half-time of 48.1 ± 0.9 min) than at 
25°C (half-time 59.6 ± 0.2 min).
Control experiments, described below, were done to 
show that changes in GP observed in the presence of rHDL 
were attributable to changes in the concentration of cho­
lesterol on the bilayer and not to other factors.
i) During the interaction of rHDL and the GUV, 
LAURDAN from the GUV may transfer to the particle. If 
rHDLs containing LAURDAN bind the bilayer, the GP 
value measured (on the bilayer) would have the contribu­
tion of the intensity coming from the LAURDAN mole­
cules solubilized both at the GUVs and in the rHDLs 
(equation 2). In a standard kinetic experiment, the total 
intensity from the target GUV labeled at a LAURDAN/ 
lipid ratio of 1:300 is 60,000 counts on average per chan­
nel. A 0.35 |jlM solution of rHDL (the concentration used 
in all experiments) labeled at a LAURDAN/lipid ratio of 
1:300 shows ' j200 counts on average (i.e., on the order of 
background noise). Thus, because of their low concentra­
tion, the intensity contribution of the LAURDAN in the 
rHDL to the total GP value measured in the GUV will be 
negligible, and no changes in the GP of the bilayer can be 
attributed to the LAURDAN in the rHDL. Binding of the 
Time (minutes)
Fig. 2. Changes in 6-lauroyl-2-(dimethylamino) naphthalene 
(LAURDAN) GP of POPC (asterisks) and POPC/FC (2:1) GUVs 
(symbols) after die addition of 0.35 pM 78 À rHDL. Different sym­
bols (squares, circles, and diamonds) correspond to diree sets of 
experimental data at 25°C (open symbols) and 37°C (closed sym­
bols). Solid lines correspond to the first-order exponential decay 
fitting for die average of die diree experimental data sets.
particles to the POPC/FC GUVs was tested using rHDLs 
containing Alexa 488-labeled apoA-I (17) at the same con­
centration used in all experiments (0.35 ptM), and no bind­
ing was detected during 2 h of incubation. In addition, we 
previously observed that under the same experimental 
conditions, 78 A rHDLs bind to pure POPC GUVs (17) , 
and we show here that this binding did not change the GP 
of the bilayers in a 2 h period (Fig. 2).These results indi­
cate that even if rHDLs bind to the membrane, the GP of 
the GUV will not be modified.
ii) To achieve net zero cholesterol efflux, GUVs made of 
POPC/FC (2:1) were incubated with 0.35 p,M rHDL con­
taining the same POPC/FC ratio. No changes in GP value 
were observed during the 2 h observation period.
Hi) Finally, as a negative control, we used lipid-free 
apoA-I. The lipid-free protein is known to require the pres­
ence of the ABCA1 transporter to remove FC; therefore, 
it is not expected to show significant cholesterol removal 
from artificial membranes. Incubation of POPC/FC GUVs 
with 0.35 |jlM apoA-I did not change the GP values after the 
2 h incubation (data not shown).
rHDL during cholesterol removal
To study the behavior of 78 A rHDL during cholesterol 
removal, we used FCS. In Fig. 3A, we show an intensity 
image of an unlabeled POPC/FC GUV after 2 h of incu­
bation with Alexa 488 rHDL. The laser beam was localized 
in the solution close to the bilayer, and FCS measurements 
were performed at different times. Time zero corresponds 
to a measurement taken immediately after the addition of 
the labeled particle to the solution. Figure 3B shows the 
changes in diffusion coefficient of the 78 A rHDL particles 
during the incubation period.
The theoretical diffusion coefficient of a molecule can 
be calculated using the Stokes-Einstein equation (39); in 
the case of 78 A rHDL with a molecular mass of ~70,000 Da, 
this value is ~51 p,m2/s. The experimental diffusion coef­
ficient calculated from the autocorrelation analysis at time 
zero is 48 ± 3 p,m2/s and decreases with the incubation 
time to 32 ± 4 |xm2/s (Fig. 3B). The photon-counting 
histogram analysis (Fig. 3C) indicates that the brightness 
of the molecules does not change during the 2 h experi­
ment. These results imply that the aggregation state of the 
molecule does not change and the process of cholesterol 
removal is carried out by individual rHDL particles, which 
increase in size during the interaction.
Distribution of cholesterol at the bilayer
To analyze the influence of lateral phase organization 
on lipid removal, we first characterized GUVs made of two 
raft-like mixtures: DOPC/DPPC/FC (1:1:1) and POPC/ 
SPM/FC (6:1:1). We chose DOPC for the first ternary mix­
ture because this mixture is already well characterized in 
the literature (45). Figure 4A shows the GP values ver­
sus temperature for the DOPC/DPPC/FC mixture. Above 
32°C, the GP image is homogeneous and one GP value is 
obtained (image at 36°C in Fig. 4A), as is the case for 
POPC/FC (Fig. 1A). Below 32°C, a clear separation of two
Downloaded from www
 jlr.org by guest, on August 23, 2019
Interaction of HDL particles with membranes containing cholesterol 1693
55
JO
UR
NA
L 
O
F L
IP
ID
 R
ES
EA
RC
H 
jg
AS
BM
B
Time (minutes) Counts
Fig- 3- Interaction of 78 A rHDL with POPC/FC (2:1) GUVs followed by fluorescence correlation spectroscopy (FCS). A: Fluorescence 
image of an unlabeled POPC/FC GUV after 2 h of incubation with 0.35 pM Alexa 488-labeled 78 A rHDL. B: Diffusion coefficient obtained 
from die autocorrelation analysis of FCS data taken during a 2 h period in die soludon outside die GUV close to the membrane. The 
experimental data fitted to a one-exponent decay widi a time constant of 30.7 ±11 min. C: Photon-counting histogram analysis of the first 
(squares) and last (circles) records from the kinedcs shown in B. In B and C, symbols correspond to die experimental data and die line 
corresponds to die best fit.
macroscopic phases occurs (image at 25°C in Fig. 4A) and 
two GP values can be calculated, as explained in Methods 
and reported for each temperature. Phase separation is 
observed in 100% of the vesicles in the chamber for all of 
the experiments performed, and after a short time at this 
temperature, domains do not move significantly. Control 
experiments show constant GP values and areas for both 
phases during a 2 h period, indicating that the reported 
changes in the area and the GP cannot be attributed to 
small movements of the entire GUV and/or the domains 
(data not shown). The image at 27°C (inserted in the plot 
of Fig. 4A) shows the GUV structure at the transition be­
fore total phase separation occurs; this structure lasts a 
few minutes and can be observed if the temperature is 
decreased slowly. This image shows small "islands” of higher 
GP (0.495) appealing as "floating” in a matrix of lower 
GP (0.299).
In the case of the POPC/SPM/FC mixture, above 30°C 
only one phase is observed (Fig. 4B) and the average GP 
is constant over the entire GUV. Below 30°C, a clear 
separation of two macroscopic phases occurs and two GP 
values are calculated for each temperature. These GUVs 
are extremely heterogeneous in size, and ^60% of the 
vesicles in the chamber exhibit phase separation. The 
observed high-GP domains are small (probably one-sixth 
to one-tenth of the low-GP domains) and vary in size 
among GUVs in the same chamber and between experi­
ments. The results described below pertain to those 
vesicles in which larger domains were found.
To study the interaction of the rHDL particles with the 
two raft-like mixtures, two temperatures were chosen: one 
above the transition temperature, at which one homoge­
neous phase can be observed, and a second below the 
transition temperature, at which two liquid phases coexist 
(12, 45).
Interaction of rHDL with DOPC/DPPC/FC (1:1:1)
With the purpose of predicting the direction of the 
changes in GP value when cholesterol is removed from 
DOPC/DPPC/FC, we compared this mixture with DOPC/ 
DPPC. The GP-versus-temperature plot for the two mix­
tures is shown in Fig. 5A and repeated in Fig. 5C for 
comparison purposes. At 60°C, both mixtures present a 
homogeneous phase and one GP value is reported. Below 
45°C (for the binary mixture) and <36°C (for the ternary 
mixture), phase separation is observed and two GP values 
are reported.
Figure 5A shows the comparison of the two mixtures at 
36°C. At this temperature (solid vertical line), the mixture 
containing cholesterol presents one homogeneous phase 
and therefore one GP value (intersection of the temper­
ature line and the closed circles curve), whereas the same 
mixture without cholesterol shows domain coexistence 
and their respective GP values are shown by the intersec­
tion of the solid line with the open circles curve. Thus, the 
expected changes if cholesterol is removed under these 
conditions are a phase separation and the corresponding 
change from one to two GP values, in the direction indi­
cated by the arrows. Figure 5B shows the time-dependent 
GP changes after the addition of 0.35 p,M 78 A rHDL [a 
concentration that was effective for removing cholesterol 
from POPC/FC GUVs (Fig. 2)]. No changes in GP value 
were observed in a 2 h period, indicating that no choles­
terol is being removed. Instead, incubation with 0.25 mM 
MpCD induced a GP change from 0.37 to 0.15 (Fig. 5B, 
diamonds) , but no phase separation was observed. This last 
observation might be attributable to the lower concentra­
tion of MpCD used in this study compared with previously 
reports, in which phase separation was observed (46).
In a similar manner, Fig. 5C shows the expected GP 
changes if cholesterol is removed from a DOPC/DPPC/
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Fig. 4. Changes in GP as a function of the temperature of DOPC/DPPC/FC (1:1:1) (A) and POPC/SPM/ 
FC (6:1:1) (B). Symbols correspond to the average GP of 10 independent GUVs. Above phase separation, 
one average GP is presented; below transition temperature, two phases coexist and two GP values are plotted 
for each temperature. GP images at right show the center and top views of a GUV at the working temperature 
for each mixture. Panel A also shows dre top view of a DOPC/DPPC/FC (1:1:1) GUV at 27°C.
FC (1:1:1) mixture at 25°C. At this temperature, both mix­
tures (with and without cholesterol) show phase separa­
tion. The expected changes if cholesterol is removed are 
an increase in the GP value of the higher GP phase and a 
decrease of the GP of the lower GP phase. Figure 5D shows 
the time-dependent changes of the GP value for both 
phases after the addition of 0.35 pAI 78 Â rHDL. The GP 
value of the higher GP phase (circles) did not change sig­
nificantly, similar to the results at 36°C. However, the GP 
value of the lower GP phase (squares) did show a decrease 
during the incubation. This observation suggests a prefer­
ential cholesterol removal from the lower GP phase by 
rHDL. No significant changes in the area of the coexisting 
phases or the size of the GUV were observed.
Interaction of rHDL with POPC/SPM/FC (6:1:1)
Using a similar rationale, we analyzed the influence of 
phase separation on cholesterol removal from POPC/ 
SPM/FC (6:1:1) GUVs. At 37°C, the intersection of the 
solid line with the GP ci lives in Fig. 6A indicates that a 
decrease in GP (from the closed circle cuive toward the 
open circle cuive) without phase separation is expected 
if cholesterol is removed. Experimental data from after 
the addition of 0.35 p,M 78 A rHDL show no significant 
changes during the obseived period of 2 h (squares in 
Fig. 6B) , indicating, similar to the POPC/DPPC/FC mixture 
at 36°C (Fig. 5B), that no cholesterol is being extracted.
At 23°C, the expected result if cholesterol is removed 
from the GUV is a decrease in the GP value in both coexist­
ing phases (Fig. 6C). In agreement with the observations 
using the previous mixture, a decrease in GP value is ob­
served in the lower GP phase (blue circles in Fig. 6D) but 
not in the higher GP domains (orange squares in Fig. 6D). 
This result indicates that also for this mixture, rHDL pref­
erentially removes cholesterol from the lower GP phase.
During the interaction, the higher GP domains tended 
to move, making the quantification of the areas difficult; 
however, it was obseived that a clear decrease in size (area) 
of these domains was sometimes accompanied by a de­
crease in the overall size of the GUVs (Fig. 6D).
DISCUSSION
In this work, we used an original experimental design to 
demonstrate that cholesterol removal by rHDL depends
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Fig. 5. DOPC/DPPC/FC (1:1:1) GUVs plus cholesterol acceptors. Expected GP changes (A, C) and kinetics (B, D) for cholesterol re­
moval at 36°C (upper panels) and 25 °C (lower panels). A, C: GP values at each temperature are shown wide closed or open circles for GUVs 
containing or not containing FC, respectively. If FC is removed at the temperatures indicated by die solid vertical lines, GP is expected 
to change from die initial values (closed circles) in the direction shown by the white arrows toward die GP values widi no FC (open circles). 
B: GP changes after die addition of 0.35 pM 78 A rHDL (squares) and 0.25 mM M[3CD (diamonds) to DOPC/DPPC/FC (1:1:1) GUVs 
at 36°C. Lines represent die linear square fit of the experimental data. D: GP changes after die addition of 0.35 pM 78 A rHDL to DOPC/ 
DPPC/FC (1:1:1) GLTVs at 25°C. GP kinetics for die liquid-ordered (lo) phase (circles) and the liquid-disordered (ld) phase (squares) are 
shown separately.
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on lipid phase fluidity. We have previously shown that 
LAURDAN GP imaging with two-photon excitation and a 
dual-channel microscope offers a well-suited methodology 
to study lipid-protein interaction with high spatial resolu­
tion (25, 36). Here, we show the usefulness of this tech­
nique to quantify the kinetics of cholesterol removal from 
different membrane pools simultaneously.
First, we set out to establish the feasibility of our tech­
nique. Experiments with homogeneous liquid POPC/FC 
bilayers (Fig. 1) show that GP measurements are sensitive 
to changes in cholesterol content in the membrane ac­
cording to a linear relationship up to a cholesterol con­
centration of 45%. Although previous work by Parasassi 
et al. (44, 45) shows that some discontinuities in the linear 
behavior could be present, differences in technical condi­
tions could explain this apparent discrepancy.
Second, we showed the correlation between changes 
in GP values at the bilayer and the concentration of the 
cholesterol acceptor used in this work, MpCD, and rHDL. 
Finally, we set out to characterize the lipid packing of the 
mixtures used and their behavior under cholesterol deple­
tion. We used three well-characterized model systems: one 
binary mixture (POPC/FC) and two ternary raft-like mix- 
tures, DOPC/DPPC/FC (1:1:1) andPOPC/SPM/FC (6:1:1).
The phase diagram for POPC plus different cholesterol 
concentrations has been described (47). One feature of 
this phase diagram is the observation over a wide temper­
ature range of a fluid but highly ordered phase (lo) at 
bilayers with cholesterol concentrations > 25 mol% (as we 
used here). This lo phase has universal characteristics that 
are relatively independent of the precise chemical struc­
ture of the phosphocholine molecule.
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Fig. 6. POPC/SPM/FC (6:1:1) GUVs plus 78 Â rHDL particles at 23°C and 37°C. Expected GP changes (A, C) and kinetics (B, D) for 
cholesterol removal at 37°G (upper panels) and 23°G (lower panels). A, G: GP values at each temperature are shown wide closed or open 
circles for GLTVs containing or not containing FG, respectively. If FG is removed at the temperatures indicated by die solid verdeal lines, 
GP is expected to change from the initial values (closed circles) in die direction shown by die arrows toward die GP values widi no FG (open 
circles). B, D: Kinetics data taken after die addition of 0.35 pM 78 Â rHDL to POPC/SPM/FC (6:1:1) at 23°C and 37°C. GP values for lo 
(orange) and ld (blue) are shown separately. Lines represent die linear square fit of die experimental data. Images correspond to the GLTV 
in die beginning (left) and at the end (right) of die incubation period.
Time (minutes)
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The phase diagram for the two raft-like lipid compositions 
is also available, and depending on the temperature, they 
present one ld phase or a lo/ld phase coexistence (12, 22, 
45, 48, 49). The DOPC/DPPC/FC (1:1:1) mixture has been 
characterized by Veatch et al. (45). In our study, this mixture 
presents a phase separation at 33 ± 1°C. Above this value, 
one homogeneous GP characterizes the sample. Below this 
value, two phases with different GP coexist. All of these ob­
servations are in agreement with the studies done by Veatch 
et al. (45), who reported a transition between a homoge­
neous lo phase and a coexistence of lo/ld phases at 32°C.
The second raft-like mixture was POPC/SPM/FC at a 
molar ratio of 6:1:1. The phase diagram at the two working 
temperatures has been reported by de Almeida, Fedorov, 
and Prieto (48) , and the mixture presents lo/ld phase co­
existence at 23°C and a homogeneous ld phase at 37°C. 
Our GP images in Fig. 4A show the homogeneous phase at 
37°C and the phase separation at 23°C, in agreement with 
the data of Almeida, Fedorov, and Prieto (48).
The importance of cholesterol packing for 
rHDL-mediated lipid solubilization
Rothblat et al. (50) proposed that lipid packing may de­
fine several pools in the membrane, from which cholesterol 
can be removed with different kinetic properties. NMR 
studies reported that cholesterol desorption may be facili­
tated from phases in which interactions of phospholipids 
and cholesterol are weak (45). Our data support this view 
and show in real time that lipid packing determines the
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kinetic properties of cholesterol removal. We show that 
rHDLs solubilize cholesterol from POPC/FC GUVs at 25°C 
and 37°C and from ld domains coexisting with the lo phase, 
but not from homogeneous ld phases of the same mixture.
To explain our results, we looked at the molecular in­
teractions between lipids and cholesterol in the different 
phases. The coexisting ld phases are enriched in the un­
saturated phospholipid (DOPC or POPC), but they also 
contain a percentage of the saturated lipid (DPPC or SPM) 
(45, 51). Clearly, the presence of small amounts of DPPC 
or SPM is not an impediment to the free diffusion of cho­
lesterol to the rHDL. The unsaturations present in the acyl 
chains of POPC or DOPC introduce kinks that limit the 
ability of cholesterol to order, to mix homogeneously, to 
reduce interfacial elasticity (52), and to decrease in-plane 
elasticity (51) Thus, kinks in the lipids forming the ld 
phases (DOPC and POPC) will prevent the deep penetra­
tion that is possible with the rigid acyl chains of DPPC and 
SPM. Cholesterol will thus locate more superficially and 
will more easily desorb from the membrane to the aqueous 
interface and transfer to the rHDL. Similar reasoning can 
be applied to the cholesterol present in the universal lo 
phase described for POPC/FC (2:1) (47) , from which the 
rHDL removes cholesterol as well.
On the other side, the coexisting lo phases are formed 
mainly by DPPC or SPM and contain a small percentage 
of unsaturated lipid DOPC or POPC. DPPC has a chain 
structural motif more similar to natural sphingolipids than 
to naturally predominant phosphocholines, which are un­
saturated (52). 2H-NMR data suggest that the hydrophobic 
thickness of the lipid bilayer is much larger than the 20 A 
of the cholesterol molecule and that the average acyl chain 
length, in each leaflet, is significantly shorter than the 
length of cholesterol (53). Thus, cholesterol molecules 
locate part of their tail in the adjacent bilayer (54) , allow­
ing the formation of tail-to-tail dimers (55) and then im­
peding its desorption.
When ternary mixtures are at 37°C, one homogeneous 
ld phase exists from which particles are not able to remove 
cholesterol. Compared with the coexisting ld phase, this 
homogeneous ld phase contains more DPPC or SPM, which 
makes cholesterol nonaccessible to the rHDL and thus the 
kinetics of transfer much slower.
The observation that MpCD was able to remove cho­
lesterol from GUVs at 37°C, whereas rHDL could not, may 
have an explanation in the different mechanisms for cho­
lesterol removal used by these particles. It has been pos­
tulated that cholesterol has to desorb completely from the 
plasma membrane into the aqueous medium before it 
can be absorbed by the rHDL (8). In contrast, the MpCD 
mechanism appears to involve the direct incorporation of 
cholesterol into the hydrophobic cavity of the cyclodextrin 
molecule, without the necessity of its traveling through an 
intermediate aqueous phase (56-58).
Importance of the acceptor
Even though rHDLs have been used extensively as a 
model system in studies referring to cholesterol removal 
(16, 17), not much attention has been focused on the 
particle itself. We show here that the acceptance of cho­
lesterol by rHDL modifies its diffusion (i.e., its size). The 
FCS data taken outside the GUV membrane indicate that 
rHDLs act as independent units in the process of choles­
terol removal. The lipid molecules are incorporated into 
the particle, and the consequent increase in size is evident 
in a decrease in lateral mobility observed. It is possible that 
during the interaction of the particles with the bilayer, 
some phospholipids are removed in addition to choles­
terol. We have shown this previously by analyzing the re­
arrangement of 78 A rHDLs during the interaction with 
phospholipid vesicles (17). These observations are impor­
tant, as apoA-I conformation is strongly dependent on par­
ticle size (59) , and its interaction with membranes, as well 
as its lipid diffusion mechanism, must change upon lipid 
enrichment. Although rHDLs are more lipidated than 
natural preP-HDLs isolated from human plasma, these 
observations support our previous hypothesis that the me­
tabolic dynamics of discoidal lipid-poor HDLs could occur 
in vivo during reverse cholesterol transport (59). Smaller 
prepi-HDLs, containing an apoA-I conformation that 
makes the particle highly efficient at lipid removal, could 
solubilize lipids from the cell membrane, acquiring a new, 
larger conformation prone to desorption and further me­
tabolism (59). The binding of the rHDL to the membrane 
calls for further detailed kinetics studies that may use the 
high spatial and time resolution provided by scanning 
FCS (60) and raster image correlation spectroscopy tech­
niques (61).
The use of MpCD as an alternative cholesterol acceptor 
leads to another important observation. By comparison of 
the concentrations used (Fig. IB, C), rHDLs are ~l,000 
times more efficient than MpCD at removing cholesterol 
from POPC/FC GUVs at 25°C. This observation is impor­
tant for future studies, because MpCD is widely used to 
remove cholesterol in vivo and can be toxic for some cells 
as a result of the high concentration needed. HDL par­
ticles, on the other hand, even at high concentrations, may 
not present this problem and may be an alternative tool in 
these types of studies.
A model for the transference of cholesterol from 
coexisting phases
Based on our observations of cholesterol removal 
from coexisting lo/ld phases, we propose a model for 
cholesterol removal by rHDL that may be extended to 
other acceptors.
When cholesterol is distributed between two lipid 
phases, there is an equilibrium between the cholesterol 
content in both phases. This equilibrium depends on 
temperature, the type of lipid in each phase, and the 
amount of cholesterol present, among other factors (12, 
49, 50, 62, 63). If cholesterol content in one of the phases 
changes, a new equilibrium will be established in seconds 
that is much faster than the rate at which GP points are 
taken (Figs. 5, 6A, B). For the two raft-like mixtures studied, 
rHDLs remove cholesterol from the ld phase. To reestab­
lish the equilibrium between the phases, cholesterol mole-
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cules would have to move from the lo to the ld phase. Based 
on the speed of cholesterol movement between the phases 
and the speed of the transfer of cholesterol to the rHDL, 
our results can be explained in two cases.
In case 1, cholesterol is removed from the ld phase and 
could rapidly equilibrate in the two phases according 
to their respective affinities. Although some lateral cho­
lesterol diffusion could occur to reequilibrate the phases, 
if the total cholesterol concentration remains high, the lo 
phase do not disassemble. This is the case for the first 
mixture [DOPC/DPPC/FC (1:1:1)]. Cholesterol is re­
moved from the ld phase, with no changes in the area 
of the lo phase, until either the capacity of the HDL parti­
cle is reached or the available cholesterol of this phase 
is depleted.
In case 2, cholesterol is removed from the ld phase and 
could be slowly replenished from the lo phase to achieve 
reequilibration. If the total cholesterol concentration is 
low, the border of the phase could disassemble before the 
rest of the phase. This is the case with the second mixture 
[POPC/SPM/FC (6:1:1)]. As cholesterol is removed from 
the ld phase, the lo phase decreases in size as reequili­
bration occurs (Fig. 6D). We did not see the total disap­
pearance of the lo domains, but we expect that higher 
concentrations of the acceptor will produce such an effect. 
This part of our model also explains the experiments 
described recently by Puff et al. (20) using the mixture 
POPC/SPM/FC (55:5:20) and plasma HDL.
Finally, we show that LAURDAN GP imaging and two- 
photon microscopy are a powerful combination of tech­
niques, which provide both the high spatial resolution and 
real-time data acquisition to follow cholesterol removal 
from different domains simultaneously. This fact suggests 
the potential for using GP imaging in vivo. The exis­
tence of macro domains in vivo has been reported using 
LAURDAN GP imaging (64), but in general, phase 
separation is difficult to visualize. Clearly, careful attention 
must be taken with in vivo studies, in which the phase 
separation is not as well defined as in artificial systems, 
especially when removal of cholesterol from one domain 
can affect not only other domains on the membrane but 
also cellular storage locales and proteins immersed in the 
membrane. The combination of two-photon microscopy, 
GP measurements, and FCS provides a powerful approach 
to the problem in vitro and in the future could be applied 
to in vivo studies.Efl
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